Table 2 Guideline score according to score on each of the domains assessed by the AGREEII instrument
Title | Scope and Purpose | Stakeholder | Rigour | Clarity | Applicability | Editorial Independence | Recommendation |
|---|---|---|---|---|---|---|---|
American Gastroenterological Association Medical Position Statement: Guidelines on Constipation [9] | 31 % | 11 % | 7 % | 44 % | 15 % | 0 % | Not recommended |
Practice Guidelines for the Management of Constipation in adults [10] | 44 % | 22 % | 36 % | 44 % | 25 % | 0 % | Not recommended |
Prevention of constipation in the older adult population [11] | 81 % | 39 % | 58 % | 72 % | 54 % | 54 % | Strongly recommended |
Management of chronic constipation: recommendations from a consensus panel [12] | 39 % | 14 % | 9 % | 53 % | 17 % | 33 % | Not recommended |
Evaluation and Treatment of Constipation in Infants and Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition [13] | 56 % | 31 % | 46 % | 58 % | 31 % | 0 % | Recommended |
Putting evidence into practice:evidence-based inventions for the prevention and management of constipation in patients with cancer [14] | 64 % | 28 % | 45 % | 47 % | 33 % | 0 % | Recommended |
The management of constipation in palliative care: clinical practice recommendations [15] | 56 % | 17 % | 41 % | 67 % | 23 % | 21 % | Not recommended |
Management of constipation [16] | 75 % | 31 % | 63 % | 67 % | 44 % | 29 % | Recommended |
National Consensus on The Management of Constipation in Indonesia 2010 [17] | 56 % | 8 % | 3 % | 69 % | 10 % | 0 % | Not recommended |
Constipation in Children and Young People: Diagnosis and Management of Idiopathic Childhood Constipation in Primary and Secondary Care [18] | 78 % | 61 % | 50 % | 75 % | 54 % | 71 % | Strongly recommended |
Consensus Recommendations for the Management of Constipation in Patients with Advanced, Progressive Illness [19] | 50 % | 19 % | 40 % | 64 % | 21 % | 50 % | Recommended |
Prucalopride for the treatment of chronic constipation in women [20] | 56 % | 39 % | 33 % | 72 % | 58 % | 50 % | Recommended |
Common views on diagnosis and treatment of chronic constipation with Chinese medicine [21] | 17 % | 8 % | 11 % | 56 % | 23 % | 0 % | Not recommended |
World Gastroenterology Organisation Global Guideline Constipation-A Global Perspective [22] | 36 % | 14 % | 14 % | 47 % | 21 % | 83 % | Not recommended |
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation [23, 24] | 50 % | 19 % | 48 % | 50 % | 21 % | 17 % | Not recommended |
Practical Treatments for Constipation in Korea [25] | 44 % | 11 % | 16 % | 39 % | 21 % | 33 % | Not recommended |
Diagnosis and Treatment Guideline of Chronic Constipation in China [26] | 25 % | 11 % | 15 % | 47 % | 19 % | 0 % | Not recommended |
Evaluation and Treatment of Functional Constipation in Infants and Children: Evidence-Based Recommendations From ESPGHAN and NASPGHAN [27] | 81 % | 25 % | 66 % | 83 % | 23 % | 38 % | Recommended |
Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool [28] | 50 % | 36 % | 22 % | 53 % | 23 % | 38 % | Recommended |
American Gastroenterological Association Medical Position Statement on Constipation [29] | 33 % | 17 % | 25 % | 61 % | 42 % | 25 % | Not recommended |
Lubiprostone for treating chronic idiopathic constipation [30] | 75 % | 39 % | 46 % | 44 % | 38 % | 67 % | Recommended |
Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation [31] | 42 % | 22 % | 15 % | 36 % | 25 % | 42 % | Not recommended |
Total (\( \overline{X} \)±SD) | 51.77 ± 18.24 | 23.73 ± 13.16 | 32.23 ± 19.24 | 56.73 ± 12.91 | 29.14 ± 13.55 | 29.59 ± 25.91 | - |